Literature DB >> 20960483

Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease.

Gisela Llebaria1, Javier Pagonabarraga, Mercè Martínez-Corral, Carmen García-Sánchez, Berta Pascual-Sedano, Alexandre Gironell, Jaime Kulisevsky.   

Abstract

The development of visual hallucinations (VH) is a frequent complication of Parkinson's disease (PD). Presence of hallucinations is one of the main risk factors associated with dementia, and severity progression of VH mainly contributes to impaired quality of life in PD. The neuropsychological features associated with severity progression of VH are unknown and might help to detect patients at risk of a more severe outcome. We aimed to explore the neuropsychological deficits associated with the different types of VH observed in PD, from minor hallucinations to well-formed VH with loss of insight. Prospective study of 57 PD patients with (n = 29) and without VH (n = 28) matched for age, education, antiparkinsonian medications, and disease duration. Description of VH was assessed by the Hallucinations and Psychosis item of the MDS-UPDRS. Cognition was assessed with the Parkinson's Disease-Cognitive Rating Scale (PD-CRS) and the Mattis Dementia Rating Scale (MDRS). Patients with minor VH did not differ from patients without VH in any cognitive domain. PD patients with major VH and insight retained performed worse on the action verbal fluency task (P < 0.04), and patients with VH and loss of insight showed a greater impairment on the PD-CRS posterior cortical score (P = 0.021) and the clock copying item (P = 0.01). A double dissociation was found in the neuropsychological profile of patients with VH with and without loss of insight. While the presence of major VH with insight retained appeared related to a predominant frontal-striatal impairment, loss of insight was characterized by further impairment of cognitive functions related to posterior cortical areas. A comprehensible continuum pattern of clinical relationships emerged among VH and cognitive functioning in PD.
© 2010 Movement Disorder Society.

Entities:  

Mesh:

Year:  2010        PMID: 20960483     DOI: 10.1002/mds.23411

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  20 in total

1.  The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease.

Authors:  James M Shine; Glenda M Halliday; Moran Gilat; Elie Matar; Samuel J Bolitho; Maria Carlos; Sharon L Naismith; Simon J G Lewis
Journal:  Hum Brain Mapp       Date:  2013-06-13       Impact factor: 5.038

2.  Advances in the treatment of visual hallucinations in neurodegenerative diseases.

Authors:  Daniel Collerton; John-Paul Taylor
Journal:  Future Neurol       Date:  2013-07

3.  Domain-specific cognitive impairment in non-demented Parkinson's disease psychosis.

Authors:  Jared T Hinkle; Kate Perepezko; Catherine C Bakker; Ted M Dawson; Vanessa Johnson; Zoltan Mari; Cherie L Marvel; Kelly A Mills; Alexander Pantelyat; Olga Pletnikova; Liana S Rosenthal; Melissa D Shepard; Daniel A Stevens; Juan C Troncoso; Jiangxia Wang; Gregory M Pontone
Journal:  Int J Geriatr Psychiatry       Date:  2017-05-16       Impact factor: 3.485

Review 4.  Psychiatric issues in cognitive impairment.

Authors:  Dag Aarsland; John-Paul Taylor; Daniel Weintraub
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

Review 5.  Parkinson's disease psychosis: therapy tips and the importance of communication between neurologists and psychiatrists.

Authors:  Daniel Martinez-Ramirez; Michael S Okun; Michael S Jaffee
Journal:  Neurodegener Dis Manag       Date:  2016-07-13

Review 6.  Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.

Authors:  Abhishek Lenka; Javier Pagonabarraga; Pramod Kumar Pal; Helena Bejr-Kasem; Jaime Kulisvesky
Journal:  Neurology       Date:  2019-07-09       Impact factor: 9.910

Review 7.  Is all cognitive impairment in Parkinson's disease "mild cognitive impairment"?

Authors:  Saül Martínez-Horta; Jaime Kulisevsky
Journal:  J Neural Transm (Vienna)       Date:  2011-06-22       Impact factor: 3.575

8.  Psychometric Properties and Characteristics of the North-East Visual Hallucinations Interview in Parkinson's Disease.

Authors:  Kelsey A Holiday; Eva Pirogovsky-Turk; Vanessa L Malcarne; J Vincent Filoteo; Irene Litvan; Stephanie L Lessig; David Song; Dawn M Schiehser
Journal:  Mov Disord Clin Pract       Date:  2017-03-16

9.  Treatment of psychosis and dementia in Parkinson's disease.

Authors:  Jennifer G Goldman; Samantha Holden
Journal:  Curr Treat Options Neurol       Date:  2014-03       Impact factor: 3.598

10.  Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.

Authors:  Carmen Gasca-Salas; Pedro Clavero; David García-García; José A Obeso; María C Rodríguez-Oroz
Journal:  Hum Brain Mapp       Date:  2015-12-14       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.